EMAIL DISCLAIMER
 
Dear Visitor,
 
Please do not send any confidential information to us. By clicking “Accept,” you acknowledge and agree that our review of the information in your email and any attachments does not establish an attorney-client relationship between you and our firm or any of our attorneys, and does not preclude our representation of other persons/parties in matters where the information is pertinent, even if the information is highly confidential or could be exploited to your disadvantage, or you submitted it in good faith to retain us.
團隊
Home >> Practices >> Patent Prosecution and Maintenance >> Kevin Cheng
鄭凱耀 Kevin Cheng

Kevin Cheng

Attorney

聯絡方式

Kevin is an attorney at Lee and Li, Attorneys-at-Law and a member of the firm's Corporate and Investment Department. His practice covers corporate investment, digital, TMT, artificial intelligence and life sciences.

Kevin regularly assists domestic and international clients in legal advisory services relating to their operations in Taiwan, drafting and reviewing Chinese and English commercial contracts, and transaction planning and execution for investment matters.

學歷

LL.M., National Taiwan University (2024)
LL.B., National Taiwan University (2018)

專業領域

Corporate and Investment; Mergers and Acquisitions - Non-Financial Institutions; Life Sciences; Digital, TMT and Data Privacy

資格

Admitted to Taiwan Bar Association (2025)

語言

2026 Amendments to the "Pharmaceutical Affairs Act" and "Articles 3 and 28 of the Drug Injury Relief Act" Enacted
LEXOLOGY
2026 Amendments to the "Pharmaceutical Affairs Act" and "Articles 3 and 28 of the Drug Injury Relief Act" Enacted
LEE & LI Bulletin - February 2026

回上一頁